Chalcone derivatives: role in anticancer therapy

Y Ouyang, J Li, X Chen, X Fu, S Sun, Q Wu - Biomolecules, 2021 - mdpi.com
Chalcones (1, 3-diaryl-2-propen-1-ones) are precursors for flavonoids and isoflavonoids,
which are common simple chemical scaffolds found in many naturally occurring compounds …

Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted …

M Liao, R Qin, W Huang, HP Zhu, F Peng… - Journal of Hematology & …, 2022 - Springer
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …

Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer

AA WalyEldeen, S Sabet, HM El-Shorbagy… - Chemico-Biological …, 2023 - Elsevier
The need for innovative anticancer treatments with high effectiveness and low toxicity is
urgent due to the development of malignancies that are resistant to chemotherapeutic …

A comprehensive review on the antiviral activities of chalcones

D Elkhalifa, I Al-Hashimi, AE Al Moustafa… - Journal of Drug …, 2021 - Taylor & Francis
Some viral outbreaks have plagued the world since antiquity, including the most recent
COVID-19 pandemic. The continuous spread and emergence of new viral diseases have …

Targeting Bcl-2 for cancer therapy

L Zhang, Z Lu, X Zhao - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2021 - Elsevier
Apoptosis deficiency is one of the most important features observed in neoplastic diseases.
The Bcl-2 family is composed of a subset of proteins that act as decisive apoptosis …

Anticancer activity of natural and synthetic chalcones

T Constantinescu, CN Lungu - International journal of molecular sciences, 2021 - mdpi.com
Cancer is a condition caused by many mechanisms (genetic, immune, oxidation, and
inflammatory). Anticancer therapy aims to destroy or stop the growth of cancer cells …

Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy

B Rioux, A Pinon, A Gamond, F Martin… - European journal of …, 2021 - Elsevier
The aim of this study was to synthesize chalcone-polyamine conjugates in order to enhance
bioavailability and selectivity of chalcone core towards cancer cells, using polyamine-based …

Advances in chalcone derivatives: Unravelling their anticancer potential through structure-activity studies

KA Sheikh, A Gupta, M Umar, R Ali… - Journal of Molecular …, 2024 - Elsevier
Cancer continues to be a global health challenge, thereby necessitating the evolution of
innovative therapeutic strategies. The synthesis of chalcone derivatives has garnered …

Recent progresses in chalcone derivatives as potential anticancer agents

J Yang, J Lv, S Cheng, T Jing, T Meng… - Anti-Cancer Agents …, 2023 - ingentaconnect.com
Chalcones are members of the flavonoid family and act as intermediates in the biosynthesis
of flavonoids, which are widespread in plants. Meanwhile, chalcones are important …

[HTML][HTML] A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 …

X Jin, Y Mei, Z Shen, J Zhu, S Xing, H Yang, G Liang… - Phytomedicine, 2022 - Elsevier
Background: Although triple-negative breast cancer (TNBC) accounts for only 15% of breast
cancer cases, it is associated with a high relapse rate and poor outcome after standard …